LFB Biomanufacturing
Emilie Henno has extensive experience in the biomanufacturing sector, currently serving as Responsable Production and Responsible DownStream Process at LFB Biomanufacturing since June 2006. Emilie has expertise in managing and planning DownStream Process (DSP) activities, implementing DSP stages in GMP units, and facilitating the transfer of processes from pilot to GMP. Additionally, Emilie is responsible for project management, including GANTT chart creation and cost estimation for production. Prior to this role, Emilie worked as a technical and scientific assistant in DSP at MAbgène from June 2006 to September 2010. Emilie holds a Licence in physical sciences with a focus on chemistry and physical-chemistry from Université Montpellier II, obtained between 1998 and 2003.
LFB Biomanufacturing
LFB Biomanufacturing is an expert CDMO in the development and manufacture of recombinant proteins via cell culture, with specific know-how in the area of monoclonal antibodies (mAbs). LFB Biomanufacturing supplies a full range of bioproduction services, from the development of cell lines to the manufacturing clinical and commercial batches of active substances from biological products up to multiple pool of 2000L Cell Culture production capacities using Disposable Bioreactors Technology and exclusively Single-Use systems. The Alès site is regulary inspected by Customers as well as Health Agencies, including French-ANSM and US-FDA. LFB Biomanufacturing is subsidiary of the LFB Group.